United Therapeutics Corporation (Nasdaq: UTHR ) today announced positive results from its phase 1 study of miroliver ELAP®, an external liver assist product, in patients with acute forms of liver ...
Abstract: Incorporating reliability constraints in economic dispatch is challenging considering massive system states resulting from random component failures and renewable energy (RE) uncertainties.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results